Generated September 4, 2026 at 8:34 PM ET
· Covers September 4 trading day
· 10 of 153 ready 8-Ks selected
· AI-assisted overview
Today's filings featured major corporate actions: SoundHound completed its acquisition of LivePerson, USA Rare Earth closed its merger with Serra Verde, and Greenland Mines acquired NNSR Holdings. Ionis received FDA approval for ZANVASTRO for Alexander disease, but its partner Novartis reported that pelacarsen missed its primary endpoint in a Phase 3 trial. Delisting notices were issued to SCWorx and Arcadia Biosciences for non-compliance. Additionally, America's CarMart extended its default waiver, and ASA Gold proposed converting to a BDC with Saba as manager.
regulatory
negative
materiality 0.90
September 4, 2026, 5:03 PM ET
SCWorx faces Nasdaq delisting over insufficient publicly held shares
- On Sept 2, 2026, Nasdaq notified SCWorx it fails 500,000 publicly held shares rule; company had 89,782.
- 1-for-12 reverse split effective Aug 3, 2026 cut public float; bid price compliance not regained per Rule 5810(c)(3)(A).
- Also non-compliant with $1M MVPHS and bid price rules; must present views to Panel by Sept 9, 2026.
M&A
positive
materiality 0.90
September 4, 2026, 4:41 PM ET
SoundHound completes LivePerson acquisition; appoints John Collins CFO
- Acquisition closed: LivePerson shareholders get 0.4673 SOUN shares per share; TASE shares get $3.31 cash.
- Notes restructuring: First Lien holders get 25.14M SOUN shares + $2.5M cash; Second Lien get 11.75M shares + $3.35M cash.
- John Collins named CFO; base salary $465k, 65% target bonus, $150k signing bonus, equity 63% RSUs/37% PSUs.
USAR
USA Rare Earth, Inc.
M&A
positive
materiality 0.90
September 4, 2026, 7:11 AM ET
USA Rare Earth completes $300M cash + 126.8M share merger with Serra Verde
- Merger closed Sept 3, 2026: $300M cash + 126,849,307 USAR shares paid for Serra Verde.
- Serra Verde is only scaled producer of all four heavy rare earths outside Asia; ramp-up to 4,000 tpa TREO by end 2026.
- Thras Moraitis becomes President, CEO on Oct 1, 2026; Sir Mick Davis joins board.
IONS
IONIS PHARMACEUTICALS INC
regulatory
positive
materiality 0.90
September 4, 2026, 6:01 AM ET
FDA approves Ionis' ZANVASTRO (zilganersen) for Alexander disease
- ZANVASTRO is first and only disease-modifying treatment for AxD; 50 mg intrathecal quarterly.
- Pivotal study met primary endpoint: gait speed stabilization at Week 61 (LS mean diff 33.3%, p=0.041).
- FDA granted Rare Pediatric Disease Priority Review Voucher with approval.
RKDA
Arcadia Biosciences, Inc.
regulatory
negative
materiality 0.85
September 4, 2026, 4:05 PM ET
Arcadia Biosciences receives Nasdaq delisting notice for equity shortfall
- On Aug 31, 2026, Nasdaq notified Arcadia that stockholders' equity of $633,000 as of Jun 30, 2026, is below the $2.5M minimum required by Listing Rule 5550(b)(1).
- Company has until Oct 15, 2026 (45 days) to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension if plan accepted.
- If plan rejected, Arcadia can appeal to a Nasdaq Hearings Panel, which ordinarily stays suspension pending decision.
M&A
positive
materiality 0.85
September 4, 2026, 5:25 PM ET
Greenland Mines completes acquisition of NNSR Holdings for $20M cash plus 1.4M shares; Sarfartoq NPV $2.05B
- Completed merger with NNSR Holdings, acquiring Sarfartoq mineral project in Greenland; consideration $20M cash (net of expenses) plus 1,040,676 common and 359,324 Series R preferred shares.
- Initial Assessment shows pre-tax NPV ~$2.05B and IRR 118.6% (high case) based on ST1 deposit, <1% of 191 sq km license.
- Stockholders approved issuance of up to 40.8M shares on Series C conversion and 691,039 on warrants; also approved 400,000 share increase in 2024 Equity Incentive Plan.
litigation
negative
materiality 0.70
September 4, 2026, 5:09 PM ET
Grindr settles UK privacy group action for £26M; no admission of liability
- Settlement resolves UK group action over pre-2020 data practices; no admission of liability.
- Grindr to pay £13.0M by Dec 31, 2026 and £13.0M by Mar 31, 2027 (~$17.6M each at Sept 3, 2026 rate).
- Claims relate to period before 2020 when Grindr was owned by Kunlun; Grindr disputes allegations.
CRMT
AMERICAS CARMART INC
other material
negative
materiality 0.85
September 4, 2026, 5:15 PM ET
Car-Mart extends default waiver to Sept 11; strategic review active
- Lenders extended Scheduled Termination Date from Sept 7 to Sept 11, 2026 under First Amendment to Credit Agreement.
- Company has experienced or anticipates events of default, including failure to comply with financial covenants and reporting obligations.
- Strategic alternatives review continues; discussions active with third parties, Silver Point Finance (Agent), and Lenders.
ASA
ASA Gold & Precious Metals Ltd
other material
positive
materiality 0.85
September 4, 2026, 12:07 PM ET
ASA Gold proposes conversion to BDC, redomicile to Delaware, Saba as manager
- Board approved converting from gold-focused closed-end fund to BDC with yield-oriented, credit-focused strategy.
- Company to redomicile from Bermuda to Delaware and change tax status from PFIC to RIC.
- Saba Capital Management selected as new investment manager for the BDC.
IONS
IONIS PHARMACEUTICALS INC
other material
negative
materiality 0.75
September 4, 2026, 5:00 PM ET
Ionis partner Novartis: pelacarsen Phase 3 Lp(a)HORIZON misses primary CV endpoint
- Pelacarsen Phase 3 Lp(a)HORIZON did not meet primary endpoint of reducing CV events vs placebo (CV death, non-fatal MI/stroke, urgent revascularization).
- Substantially lower Lp(a) levels achieved consistent with prior studies; acceptable safety profile; full data at upcoming medical congress.
- Ionis discovered pelacarsen; Novartis licensed rights in Feb 2019; CEO Monia says results inform future cardiovascular care.